The cancer therapeutics market size is expected to reach US$ 5,31,538.02 million by 2031 from US$ 2,30,423.56 million in 2024. The market is estimated to record a CAGR of 12.8% from 2025 to 2031.

Executive Summary and Global Market Analysis

The global market for cancer treatments is growing steadily. This growth is driven by the rising number of breast and lung cancer cases and significant investments in cancer research. Cancer treatments, known as therapeutics, include many options: chemotherapy, radiation therapy, immunotherapy, and targeted and hormone therapies. The main goal of all these treatments is to either stop or cure cancer, make patients feel better, and improve their lives and survival. Treatment plans are often a mix of different therapies, carefully chosen for each patient based on their specific cancer type, stage, and overall health.

Cancer Therapeutics Market Segmentation Analysis

The market for cancer treatments can be divided into three key groups: therapy type, indication, and distribution channel. For therapy types, the market includes chemotherapy, targeted therapy, radiation therapy, hormone therapy, and others. Chemotherapy had the biggest market share in 2024. In terms of indications, the market covers blood cancer, lung cancer, breast cancer, colorectal cancer, and other specific conditions. Lung cancer represented the largest share of the market in 2024. By distribution channel, the market is split into hospital pharmacies, retail pharmacies, and online stores. Hospital pharmacies held the largest share of the market in 2024.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/BMIRE00031299

Cancer Therapeutics Market Drivers and Opportunities

A big reason for the market's growth is the global number of people with cancer. The World Health Organization says that about one in six deaths around the world is due to cancer. In 2022, there were an estimated 20 million new cancer diagnoses, and this number is expected to go up by 77% by 2050. This will put a significant strain on healthcare systems. The American Cancer Society reports that 5–10% of all cancers are inherited. Genetic mutations like those in the BRCA1 and BRCA2 genes can greatly increase the risk of developing breast, ovarian, and prostate cancers. Breast cancer is the most common cancer among women globally, and cases are rising due to environmental, genetic, and lifestyle factors.

Cancer Therapeutics Market Size and Share Analysis

When we look at the market by therapy type, the chemotherapy segment was the largest in 2024. Chemotherapy drugs work by stopping or slowing the growth of cancer cells throughout the body. These drugs travel through the bloodstream to target cancer cells everywhere. According to the National Institutes of Health, about 650,000 cancer patients in the US get chemotherapy every year. For indications, the lung cancer segment had the largest share of the market in 2024.

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications